Ewha Med J.  2011 Sep;34(2):64-66. 10.12771/emj.2011.34.2.64.

Jejunal Mass Presented by Anemia

• Noh GT
• Koo HS
• Lee RA

• KMID: 2283973
• DOI: http://doi.org/10.12771/emj.2011.34.2.64

Abstract

No abstract available.

MeSH Terms

Anemia

Figure

• 

  Fig. 1 Abdominal computed tomography findings. 6.7×6.2 cm sized mass with cavitary lesion is visible in the left upper quadrant.

• 

  Fig. 2 Macroscopic finding. 8×6 cm sized mass involved the wall of jejunum and the mucosa showed a deep ulceration.

• 

  Fig. 3 Microscopic findings. (A) Haematoxylin & eosin stain (×400) shows more than 5 atypical mitoses with spindle cell arrangement. (B) Immunohistochemical stain for c-kit (×400) shows nuclear and cytoplasmic positivity in interstitial cells.

Reference

1. Miettinen M, Lasota J. Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001. 438:1–12.

2. Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, et al. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 1987. 6:3341–3351.

3. Ranchod M, Kempson RL. Smooth muscle tumors of the gastrointestinal tract and retroperitoneum. Cancer. 1977. 39:255–262.

4. Shiu MH, Farr GH, Papachristou DN, Hajdu SI. Myosarcomas of the stomach: natural history, prognostic factors and management. Cancer. 1982. 49:177–187.

5. Ueyama T, Guo KJ, Hashimoto H, Daimaru Y, Enjoji M. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer. 1992. 69:947–955.

6. Miettinen M, El-Rifai W, Sobin LH, Lasota J. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol. 2002. 33:478–483.

7. Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Bruker BJ, et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther. 2000. 295:139–145.